PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28846937-0	2017	A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation.	BTYNB	24-29	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	39-44	
28846937-5	2017	The small molecule, BTYNB, was identified as a potent and selective inhibitor of IMP1 binding to c-Myc mRNA.	BTYNB	20-25	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	97-102	
28846937-7	2017	BTYNB destabilizes c-Myc mRNA, resulting in downregulation of c-Myc mRNA and protein.	BTYNB	0-5	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	19-24	
28846937-7	2017	BTYNB destabilizes c-Myc mRNA, resulting in downregulation of c-Myc mRNA and protein.	BTYNB	0-5	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	62-67	
28846937-13	2017	With its ability to target c-Myc and to inhibit proliferation of difficult-to-target melanomas and ovarian cancer cells, and with its unique mode of action, BTYNB is a promising small molecule for further therapeutic evaluation and mechanistic studies.	BTYNB	157-162	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	27-32